依达拉奉注射液治疗颅脑外伤脑梗死的治疗分析

Treatment analysis of edaravone injection in the treatment of traumatic cerebral infarction

目的探究并分析颅脑外伤脑梗死患者的各项临床特点和其有效的治疗方法。方法 58例颅脑外伤脑梗死患者,其中28例患者选择经常规性治疗方式治疗作为对照组,30例患者在常规治疗的同时使用依达拉奉注射液加以治疗作为治疗组,比较两组的治疗效果。结果对照组脑隙梗死、小面积梗死、大面积梗死的致死率分别为28.57%、17.86%、3.57%,合计50.00%;治疗组脑隙梗死、小面积梗死、大面积梗死的致死率分别为13.33%、6.67%、0,合计20.00%,两组比较差异具有统计学意义(P<0.05)。结论在给予手术治疗后,通过增加使用依达拉奉注射液可以有效降低颅脑外伤脑梗死患者的死亡率,增强治疗的效果。

Objective To explore and analysis the clinical characteristics of traumatic cerebral infarction, as well as its effective treatment methods. Methods There were 58 patients with traumatic cerebral infarction. 28 cases among them as control group received conventional treatment methods, and 30 cases as treatment group received additional edaravone injection. Curative effects of the two groups were compared. Results Fatality rates of lacunar infarction, small area infarction, and large area infarction in the control group were respectively 28.57%, 17.86%, and 3.57%, totally as 50.00%, and that was obviously higher than those in the treatment group as 13.33%, 6.67%, and 0, totally as 20.00%. The difference between the two groups had statistical significance （P〈0.05）. Conclusion After surgical treatment, additional use of edaravone injection can effectively reduce mortality rate and increase curative effect for traumatic cerebral infarction patients.